slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 40,861-40,890
Pages 3,683
Rows per page 30
Component
40,861-40,890 of 110,471
13
Comera | Investor Presentation Deck | 16 slidesComera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Golden Circle2 hits
14
The slide lists 11 US patents and 12 international patents, totaling 23 distinct patent identifiers.Comera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Golden Circle2 hits
04
The slide uses a modular layout to present four distinct pillars of company strength.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · Interest2 hits
21
The slide uses a split-panel layout to contrast current capabilities with future advancements.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · ActionLoop · Cost Of Inaction2 hits
15
The central diagram is a circular process flow representing the integrated offering.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Visualization2 hits
24
Eos Energy | Investor Presentation Deck | 24 slidesEos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Action2 hits
07
The slide uses a side-by-side comparison structure to detail the status and upcoming milestones for two distinct clinical programs.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)2 hits
11
The diagram uses a hub-and-spoke model to show how various scientific disciplines feed into the central 'Drug Products' core.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)2 hits
31
The slide uses a simple list-based timeline format.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations 2 hits
13
The slide uses a process-oriented layout to describe the business model.FGI Industries | Investor Presentation Deck | 30 slides · FGI Industries
Pitch deck Investor relations Beat · Solution2 hits
15
FGI Industries | Investor Presentation Deck | 30 slidesFGI Industries | Investor Presentation Deck | 30 slides · FGI Industries
Pitch deck Investor relations Beat · SolutionLoop · Why Now2 hits
07
The central diagram illustrates the mechanism of action, contrasting 'Absence of Effector T Cells' (Platinum resistant) with 'Presence of Effector T Cells' (Platinum sensitive).Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations Beat · Solution2 hits
10
The slide outlines the methodology and validation of a clinical trial.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction2 hits
05
The slide uses a causal-chain framework to link platform capabilities to strategic outcomes.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Situation & Context2 hits
27
The slide uses a two-column layout to separate milestones by drug candidate.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction2 hits
29
Includes a comparative table of clinical outcomes (ORR/CR) for NXC-201 vs. Allogeneic CAR-T and Bispecifics.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction2 hits
30
The slide uses a stylized area chart to represent market segments and their respective valuations.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction2 hits
34
The slide uses a side-by-side comparison of two disease indications, each with a list of clinical outcomes and a bottom section showing relevant market competitors and patient incidence numbers.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & Proof2 hits
61
The slide uses a 3-pillar framework to explain the platform, then maps these to specific drug candidates with detailed mechanism-of-action descriptions.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Impact & Next Steps2 hits
43
Includes a photo of Disney characters and the Disney Advertising logo.Innovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations 2 hits
45
Innovid | Investor Day Presentation Deck | 74 slidesInnovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations 2 hits
46
Innovid | Investor Day Presentation Deck | 74 slidesInnovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations 2 hits
48
The slide uses a comparison structure to link client needs (RFP drivers) to the vendor's value proposition (Why We Won).Innovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations 2 hits
30
The slide outlines the LTI (Long-Term Incentive) structure for the Chairman/CEO and Group Managing Director.Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Future Vision (Gain)2 hits
32
The slide uses a donut chart to visualize the 40/60 split of the €1.4M total remuneration.Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Future Vision (Gain)2 hits
48
The slide uses a visual metaphor of scientific research (microscope, periodic table) to represent innovation.Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Transformation2 hits
53
The slide uses a Venn diagram-like visual in the top left corner to indicate the current section of the presentation.Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Transformation2 hits
57
The slide uses a comparison structure to detail the scope, objectives, and status of two distinct corporate sustainability initiatives.Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Transformation2 hits
10
Comparison of two distinct cohorts: Healthy Volunteers (SAD/MAD) vs. HS/AD Patient Cohort.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · DesireLoop · Logic Chain2 hits
34
Includes a waterfall plot showing p53WT cell dependency on MDM2 and a biological process diagram of the MDM2-p53 feedback loop.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · Action2 hits